Skip to main content
. 2020 Nov 5;10:588195. doi: 10.3389/fcimb.2020.588195

Figure 2.

Figure 2

Survival and time-course of clinical parameters during experimental pneumococcal meningitis. No differences could be observed in survival (A), relative weight changes (B) or clinical score (C) between animals treated with ceftriaxone (CRO) or ceftriaxone combined to adjuvant JWH-133 (CRO/JWH133), neither in uninfected (PM-) nor infected (PM+) animals (PM- CRO and PM- CRO/JHW-133, n = 7; PM+ CRO and PM+ CRO/JWH133, n = 19–35, depending on the time points).